Quick screening of EGFR mutation using restriction fraction length polymorphismIchiro Kawada, Akitoshi Ishizaka, Katsuhiko Naoki et al.|Journal of Clinical Oncology|2005Cited by 3
Phase I/II trial of a low-emetic combination of S-1 plus docetaxel (DTX) for advanced non-small cell lung cancer (NSCLC).Kenichiro Komiyama, Keigo Kobayashi, Shohei Minezaki et al.|Journal of Clinical Oncology|2011Cited by 0
The docetaxel (DOC) and gemcitabine (GEM) combination as adjuvant chemotherapy in patients with non-small cell lung cancer (NSCLC): A multi-institutional phase II trialTerumoto Koike, Keisuke Eguchi, Yuichi Izumi et al.|Journal of Clinical Oncology|2006Cited by 0